今年一月,日本东京大学医科研究所附属医院向厚生省和文部省提出了肝癌基因治疗计划,他们将把过去治疗无法期待效果的6名患者作为对象,将有抑癌作用的基因移入到患者体内,以求缩小病灶来延长患者生命。厚生、文部二省于今年二月对此进行审核,年内可以得出结论。据该计划的总负 In January this year, the Affiliated Hospital of Tokyo University Medical Research Institute proposed to the Ministry of Health and Ministry of Education to plan a hepatoma gene therapy project. They will put 6 patients who can not expect the effect in the past to be targeted and transfer the gene with tumor suppressor effect into the patient’s body, In order to narrow the lesion to extend the life of patients. The two provinces, Health and Welfare Ministry and Ministry of Education and Culture, reviewed this in February this year and can reach a conclusion during the year. According to the total negative of the plan